Remove Compounding Remove Immunity Remove Pharmaceutical Companies
article thumbnail

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. Based on this ruling, 505(b)(2) drugs that are not therapeutically interchangeable should be considered sole-source drugs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

N-FIS was developed to address a critical challenge in healthcare—needle phobia

Express Pharma

Additionally, we are expanding our regulatory approvals to enter international markets and are engaging with global health organisations to integrate needle-free technology into immunization programs, making injections safer and more accessible worldwide. billion in 2028, growing at a compound annual growth rate (CAGR) of 14.16

article thumbnail

2nd Hit ID Summit

pharmaphorum

Skip to main content Friday 18 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Cancer vaccines: providing the edge in oncology

pharmaphorum

Closely related to this is the fact that global spending on oncology drugs reached $164 billion in 2020, with drug sales growing at a compound annual growth rate of 14.3% The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment. A broad front.

Vaccines 134
article thumbnail

GSK continues campaign for greater adult immunisation coverage

pharmaphorum

Mukherjee explained that the human immune system becomes weaker as people age, which leads to a greater susceptibility to catching infectious diseases and also experiencing more acute cases when infected.

article thumbnail

Getting Quality Supplements

The Thyroid Pharmacist

The truth is that most supplement companies do not undergo the same scrutiny and testing that pharmaceutical products do, because many of the tests which are required of pharmaceutical companies are voluntary for supplement companies. We have 299 expiring in March 2025.) We have 290 expiring in April 2025.)